News

Exactis Innovation featured on personalhealth.ca as part of Mediaplanet special interest campaign.

We are pleased to share an article on Precision Oncology and the Exactis PMT initiative appearing on www.personalhealthnews.ca, and printed in the April 2019 edition...
exactis

Exactis Innovation launches Investigator-Initiated Trial (IIT) Grant Competition

Exactis Innovation is pleased to formally announce the launch of the Exactis Innovation Investigator-Initiated Trial (IIT) Grant Competition. In alignment with the Exactis Mission to...
exactis

MRM Proteomics Inc and Exactis Innovation Partner to Establish Unique Clinical Proteomics Tools for Precision Medicine

MRM Proteomics Inc. is partnering with Exactis Innovation to develop and validate a clinical proteomic test that will provide clinicians and scientists with the ability...
exactis

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies

At risk cancer patients across Canada may now be able to have their tumors molecularly profiled using next-generation sequencing (NGS) as part of a national effort to...
GeneStudio

Exactis celebrates 2 years of Personalize My Treatment!

Since November 2015 (when the first PMT participant signed the PMT informed consent form) you have helped us expand PMT throughout Canada and have recruited...
exactis

Exactis Innovation brings together Quebec cancer centres to increase patient access to personalized cancer therapy

Five major Quebec cancer treatment centres are partnering with Montreal-based Exactis Innovation to build a coordinated network to match cancer patients to clinical trials based on the characteristics...
exactis

$4 million partnership to reduce barriers to the development of personalized medicine in oncology

At an announcement made earlier today, Merck confirmed its commitment to research and innovation in oncology by contributing a total of $2 million to the...
Investment cancer reasearch

Merck Canada announces $2-million grant to support personalized treatment in cancer

At the 6th Annual National Conference to Defeat Cancer, organized by Coalition Priorité Cancer, Merck Canada reinforced the company’s continued commitment to the Quebec life...
Merck Canada

$18.4 million investment to improve clinical research in cancer

The Quebec – Clinical Research Organization in Cancer (Q-CROC) was awarded a $9.2 million investment from the Quebec government over four years as part of...
Clinical research

The Government of Canada invests 15m$ in a public-private partnership to create the Centre of Excellence PreThera Research (now Exactis Innovation)

The Honourable Greg Rickford, Minister of State (Science and Technology, and Federal Economic Development Initiative for Northern Ontario) announced a $15 million investment for 5...
Canada investment
1 2